This Is Not About Surrogate Mothers

The tale of the South African grandmother pregnant with her daughter's triplets surfaced in the middle of the Fifth World Congress on In Vitro Fertilization and Embryo Transfer. But it created hardly a ripple among the scientists and clinicians gathered last month in blossom-time Norfolk, Virginia. They included all the big names of IVF as well as many who nurse big-name dreams, and they were intent on taking stock of where they are and where they're going. So intent, in fact, that news from th

Written byTabitha Powledge
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

They included all the big names of IVF as well as many who nurse big-name dreams, and they were intent on taking stock of where they are and where they're going. So intent, in fact, that news from the outside world seemed not to penetrate—let me succumb to an irresistible metaphor—the concrete zona pellucida of the convention center's appropriately round main hail.

Not even relevant news, apparently. For, unlike poor pitiful Baby M, conceived through the comparatively hoary technology of artificial insemination, the South African Three are IVF products. The laboratory-generated embryos resulted from bringing together the mother's eggs with her spouse's sperm. They were transferred into a surrogate mother who was also the mother's mother, if you follow—proving once again that truth really is stranger than the National Enquirer.

The South African stunt is the sort that gives IVF a bad name. It proclaims that some people who do ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies